Evidence map›Paper›PMID 22406000›Full record

ReviewExperimental cell research2012

Renal cancer: oxygen meets metabolism.

Volker H Haase

Abstract readReview
In one paragraph

Review in Experimental cell research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2019
    Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Journal of medical biochemistry · 2018
    Article
  7. Review
  8. HIF-prolyl hydroxylases as therapeutic targets in erythropoiesis and iron metabolism.Hemodialysis international. International Symposium on Home Hemodialysis · 2017
    Review
  9. Review
  10. Article
  11. The role of hypoxia in inflammatory disease (review).International journal of molecular medicine · 2015
    Review
  12. Article
  13. Article
  14. Gramicidin A: A New Mission for an Old Antibiotic.Journal of kidney cancer and VHL · 2015
    Article
  15. Article
  16. Cell cycle progression in response to oxygen levels.Cellular and molecular life sciences : CMLS · 2014
    Review
  17. Renal cancer-selective Englerin A induces multiple mechanisms of cell death and autophagy.Journal of experimental & clinical cancer research : CR · 2013
    Article
  18. TRP channels as sensors of oxygen availability.Pflugers Archiv : European journal of physiology · 2013
    Review
  19. Article
  20. Patterns of Expression of HIn vivo (Athens, Greece)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Volker H HaaseDepartment of Medicine, Vanderbilt School of Medicine, Nashville, TN 37232, USA. volker.haase@vanderbilt.edu
Vanderbilt Health · US

Funding

Molecular Mechanisms of Renal InjuryR01DK081646 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HAASE, VOLKER HANS · 2008 to 2021
$4.3M
Hypoxia-Inducible Factors in Liver MetabolismR01DK080821 · NIDDK · VANDERBILT UNIVERSITY · PI HAASE, VOLKER HANS · 2009 to 2013
$1.7M
NIDDK NIH HHS R01 DK080821NIDDK NIH HHS R01 DK081646
6 · The paper itself

Abstract

Over the last two decades molecular studies of inherited tumor syndromes that are associated with the development of kidney cancer have led to the identification of genes and biochemical pathways, which play key roles in the malignant transformation of renal epithelial cells. Some of these findings have broad biological impact and extend beyond renal cancer. This review's focus is on the von Hippel-Lindau (VHL)/hypoxia-inducible factor (HIF) oxygen-sensing pathway and its role in physiology, energy metabolism and tumorigenesis.

Indexed as

AnimalsCarcinoma, Renal CellHumansKidney NeoplasmsModels, BiologicalOxygenVon Hippel-Lindau Tumor Suppressor ProteinOxygenVon Hippel-Lindau Tumor Suppressor Protein

Identifiers

PMID22406000
PMCPMC3334413
OpenAlexW2093285354

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.